Brief: Sino Biopharmaceutical Announces Acquisition Of 100% Equity Interest In Hygieia
13/01/2026 09:46
Jan 13 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK: ACQUISITION OF 100% EQUITY INTEREST IN HYGIEIA MAXIMUM BASE CONSIDERATION OF RMB1.20 BILLION UNIT TO ACQUIRE 100% EQUITY INTEREST IN HANGZHOU HYGIEIA BIOMEDICAL Further company coverage: 1177.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sino Biopharmaceutical
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
Brief: Sino Biopharmaceutical Says China's CDE Accepts NDA For TQH2722 Injection
Brief: Sino Biopharmaceutical China CDE Accepts New Drug Application For TQB2102 Injection
Sino Biopharmaceutical climbs on plan to raise stake in core unit